Pangea Natural Foods Acquires Amino Innovations to Expand Health Product Line

Pangea Natural Food, Inc. ( (TSE:PNGA) ) has shared an update.

Pangea Natural Foods Inc. has acquired Amino Innovations Corp., a company specializing in innovative peptide therapies for health and wellness, through the issuance of 12 million common shares. This acquisition aims to enhance Pangea’s product offerings and market position by integrating Amino’s expertise in peptide formulations, potentially making it the world’s first needleless peptide company. The transaction includes performance-based conditions for the release of shares and a finder’s fee paid in Pangea shares.

Spark’s Take on TSE:PNGA Stock

According to Spark, TipRanks’ AI Analyst, TSE:PNGA is a Neutral.

Pangea Natural Food, Inc.’s overall stock score reflects significant financial distress and lack of profitability, despite some potential upside from recent corporate actions. The technical analysis provides a neutral outlook, while the valuation remains unattractive due to negative earnings. The company’s strategic initiatives could drive future growth, but operational and financial challenges remain substantial.

To see Spark’s full report on TSE:PNGA stock, click here.

More about Pangea Natural Food, Inc.

Pangea Natural Foods Inc. is a food manufacturing company focused on producing, co-packing, and distributing high-quality plant-based food and health products across North America.

YTD Price Performance: 22.22%

Average Trading Volume: 20,116

Technical Sentiment Signal: Buy

Current Market Cap: C$1.48M

For an in-depth examination of PNGA stock, go to TipRanks’ Stock Analysis page.